Zanubrutinib in Chronic Lymphocytic Leukemia. | N Engl J Med;388(18): 1719-1720, 2023 May 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Zanubrutinib in Chronic Lymphocytic Leukemia.

Byrd, John C; Rothbaum, Wayne.

Byrd JC; University of Cincinnati, Cincinnati, OH byrd2jc@ucmail.uc.edu.
Rothbaum W; Kartos Therapeutics, Redwood City, CA.

N Engl J Med ; 388(18): 1719-1720, 2023 May 04.

Article in English | MEDLINE | ID: covidwho-2312090

Subject(s)

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Piperidines/therapeutic use

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, B-Cell Limits: Humans Language: English Journal: N Engl J Med Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, B-Cell Limits: Humans Language: English Journal: N Engl J Med Year: 2023 Document Type: Article